Frank Orlowski | Managing Director, Supply Chain Life Sciences Practice
North Highland

Frank Orlowski is a Managing Director in North Highland’s Supply Chain Life Sciences practice, based in NYC. He has more than 25 years of experience in the pharmaceutical industry, including senior leadership roles at Pfizer. Frank specializes in manufacturing cost optimization, strategic growth planning, and operational excellence for cell and gene therapy manufacturers and pharmaceutical companies. He has led performance improvement initiatives across 35 global markets and manufacturing sites, delivering scalable strategies that enhance efficiency, reduce costs, and support growth.

Appearances:

Advanced Therapies USA 2025 - Day 1 @ 14:55

Scaling to one million patients: Cross-industry lessons for cell & gene therapy

Gene-modified cell therapies remain trapped in a high-cost, low-throughput paradigm, with ~40,000 patients treated to date versus the million-plus we must reach in the next decade. Solving the challenge demands new thinking. By fusing advanced analytics and agentic AI with proven playbooks from retail/CPG, automotive, agriculture, and fashion industries, we can compress vein-to-vein time, reduce costs, and enable quality at scale.

This session distils those insights into a five-step roadmap—people, process, data, tech, culture—to develop a scalable, adaptive value chain ready for the next million patients.

Steve Awad, CGT / Supply Chain Lead, North Highland